SOLVE SELECTIVE ONCOLYTIC VACCINIA ENGINEERING
Dead / Cancelled — Cancelled — Section 8 (as of 05 Jun 2020)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85516259
- Registration number
- 4400892
- Mark type
- Stylized text
- Filed
- 13 Jan 2012
- Published for opposition
- 27 Nov 2012
- Registered
- 10 Sept 2013
- Attorney of record
- Alicia Morris Groos
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products, drug discovery and drug delivery agents consisting of compounds for the prevention, diagnosis and treatment of cancer; pharmaceutical preparations based on a genetically engineered poxvirus platform used in the prevention, diagnosis and treatment of cancer
Owner
- SILLAJEN BIOTHERAPEUTICS, INC., San Francisco, CA, US
- Jennerex, Inc., San Francisco, CA, US
- Jennerex, Inc., San Francisco, CA, US
- Jennerex, Inc., San Francisco, CA, US
Prosecution history
- 26 Mar 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 26 Mar 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Mar 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Mar 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 26 Mar 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 05 Jun 2020 — CANCELLED SEC. 8 (6-YR)
- 10 Sept 2018 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 01 Dec 2015 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 01 Dec 2015 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 17 Dec 2014 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 10 Sept 2013 — REGISTERED-PRINCIPAL REGISTER
- 03 Aug 2013 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Aug 2013 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 01 Aug 2013 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 Jul 2013 — STATEMENT OF USE PROCESSING COMPLETE